Inventor
MIRABELLI CHRISTOPHER K
US24 patents
⚠️ This page may combine multiple inventors who share the name “MIRABELLI CHRISTOPHER K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
19 patentsUS5514788AMay 7, 1996
Oligonucleotide modulation of cell adhesion
ISIS PHARMACEUTICALS INC171 citations99
US5457189AOct 10, 1995
Antisense oligonucleotide inhibition of papillomavirus
ISIS PHARMACEUTICALS INC224 citations99
US5248670ASep 28, 1993
Antisense oligonucleotides for inhibiting herpesviruses
ISIS PHARMACEUTICALS INC140 citations99
US5514577AMay 7, 1996
Oligonucleotide therapies for modulating the effects of herpes viruses
ISIS PHARMACEUTICALS INC153 citations98
US6096722AAug 1, 2000
Antisense modulation of cell adhesion molecule expression and treatment of cell adhesion molecule-associated diseases
ISIS PHARMACEUTICALS INC106 citations97
US5681944AOct 28, 1997
Antisense oligonucleotides directed to papillomavirus
ISIS PHARMACEUTICALS INC63 citations96
US5591623AJan 7, 1997
Oligonucleotide modulation of cell adhesion
ISIS PHARMACEUTICALS INC94 citations96
US6015894AJan 18, 2000
Oligonucleotide modulation of cell adhesion
ISIS PHARMACEUTICALS INC23 citations93
US5811232ASep 22, 1998
Oligonucleotides for Papillomavirus
ISIS PHARMACEUTICALS INC20 citations93
US5658891AAug 19, 1997
Oligonucleotide therapies for modulating the effects of herpesviruses
ISIS PHARMACEUTICALS INC36 citations93
US5530114AJun 25, 1996
Oligonucleotide modulation of arachidonic acid metabolism
ISIS PHARMACEUTICALS INC46 citations91
US5843738ADec 1, 1998
Oligonucleotide modulation of cell adhesion
ISIS PHARMACEUTICALS INC16 citations82
US5665580ASep 9, 1997
Antisense oligonucleotide inhibition of papillomavirus transformed cells
ISIS PHARMACEUTICALS INC14 citations82
US6310044B1Oct 30, 2001
Oligonucleotide therapies for modulating the effects of herpesviruses
ISIS PHARMACEUTICALS INC10 citations74
US6300491B1Oct 9, 2001
Oligonucleotide inhibition of cell adhesion
ISIS PHARMACEUTICALS INC4 citations74
US6174870B1Jan 16, 2001
Antisense oligonucleotide inhibition of papillomavirus
ISIS PHARMACEUTICALS INC12 citations74
US6169079B1Jan 2, 2001
Oligonucleotide inhibition of cell adhesion
ISIS PHARMACEUTICALS INC9 citations74
US5756282AMay 26, 1998
Oligonucleotides for the diagnosis of papillomavirus
ISIS PHARMACEUTICALS INC12 citations74
US6093811AJul 25, 2000
Oligonucleotide modulation of cell adhesion
ISIS PHARMACEUTICALS INC0 citations52
SMITHKLINE BECKMAN CORP
3 patentsUS4766226AAug 23, 1988
Antitumor pharmaceutical compositions and methods for treating tumors employing α,ω-bis(disubstitutedphosphino)hydrocarbon derivatives or [α, ω-bis(disubstitutedphosphino)hydrocarbon] di
SMITHKLINE BECKMAN CORP23 citations82
US4857549AAug 15, 1989
Antitumor compounds
SMITHKLINE BECKMAN CORP11 citations74
US5037812AAug 6, 1991
Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes
SMITHKLINE BECKMAN CORP7 citations68